Načítá se...
Progenitor cell-based treatment of glial disease
Diseases of glia, including both astrocytes and oligodendrocytes, are among the most prevalent and disabling, yet least appreciated, conditions in neurology. In recent years, it has become clear that besides the overtly glial disorders of oligodendrocyte loss and myelin failure, such as the leukodys...
Uloženo v:
| Vydáno v: | Prog Brain Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5662136/ https://ncbi.nlm.nih.gov/pubmed/28554396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.pbr.2017.02.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|